1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. OPUS GENETICS INC.
Opus Genetics Inc.
XNAS: IRD
5.36 0.10 (1.90%)
1.2M
XNAS Volume

XNAS 07 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Opus Genetics Inc is on 15 May 2026 for the purpose of Opus Genetics Inc First Quarter Earnings Results for 2026 See details

Opus Genetics Inc - IRD - stock price prediction, stock price target, analyst ratings from 15 analysts

Opus Genetics Inc has a share price target of US$ 10, revenue growth forecast of 6.3%, and profit growth estimate of 1.1% for FY26, based on top 15 analyst calls.